Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT
Entera Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.57M | -2.36M | -3.02M | -2.15M | -2.02M | -2M | -2.38M | -2.33M | -2.19M | -3.04M | -3.07M | -3.19M | -3.78M | 4.92M | -2.46M | -5.15M | -9.49M |
Depreciation & Amortization | 8K | 11K | 11K | 11K | 13K | 13K | 14K | 15K | 14K | 16K | 16K | 16K | 16K | -129K | 32K | 59K | 91K |
Stock-Based Compensation | 604K | 566K | 928K | 598K | 464K | 318K | 383K | 472K | 516K | 477K | 110K | 696K | 964K | 368K | 543K | 623K | 327K |
Other Working Capital | 553K | 430.28K | -206K | 260.3K | -296K | -474.68K | 89K | 192K | -350K | 921K | -435K | -187K | -1.92M | 15K | -8K | -7K | -143K |
Other Non-Cash Items | 600K | 5.72K | 4K | 693.74K | 498K | 97.29K | -14K | -3K | -3K | -4K | -3K | -32K | -39K | -8.84M | -680K | 2.45M | 7.14M |
Deferred Income Tax | n/a | 14K | n/a | n/a | n/a | -103.35 | 29K | n/a | n/a | 23K | 214K | -30K | -33K | -217K | -6K | 2K | -52K |
Change in Working Capital | 555K | 294.28K | -76K | 206.88K | -313K | -941.63K | 442K | 282K | 54K | 512K | -139K | -292K | -1.92M | 1.24M | 514K | -55K | -290K |
Operating Cash Flow | -1.4M | -1.47M | -2.15M | -1.31M | -1.86M | -2.51M | -1.52M | -1.56M | -1.61M | -2.01M | -2.87M | -2.83M | -4.79M | -2.66M | -2.06M | -2.07M | -2.28M |
Capital Expenditures | -8K | -3K | 12K | 0.27 | n/a | -4.78K | 185.47 | -1K | -11K | -3K | -2K | -19K | -23K | -10K | -7K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 374.86 | -55K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -8K | -3K | n/a | n/a | n/a | -4.78K | 185.47 | -1K | -11K | -3K | -57K | -19K | -23K | -10K | -7K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -51K | -49K | -45K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -142K | 13K | n/a | 30K | -580K | n/a | 5K | n/a | n/a | n/a | 13K | n/a | 166K | 173K | 3.23M | 296K |
Financial Cash Flow | 13.34M | 3.22M | 13K | 1.21M | 30K | 6.03M | -77.28 | 5K | n/a | -88.6 | -101.68 | 13K | n/a | 21K | 2.58M | 12.67M | 10.11M |
Net Cash Flow | 11.91M | 1.75M | -2.14M | -125K | -1.76M | 3.43M | -1.52M | -1.55M | -1.62M | -2.01M | -2.93M | -2.83M | -4.82M | -2.43M | 469K | 10.54M | 7.79M |
Free Cash Flow | -1.41M | -1.47M | -2.15M | -1.31M | -1.86M | -2.51M | -1.52M | -1.56M | -1.62M | -2.01M | -2.87M | -2.85M | -4.82M | -2.67M | -2.06M | -2.07M | -2.28M |